Top in hem/onc: Second cancer in survivors, GERD linked to cancer risk
Click Here to Manage Email Alerts
Cancer survivors developing a second, different cancer is a concern among physicians. Various factors, including prior treatment, can potentially increase a patient’s risk for developing another malignancy, experts said.
A closer look at the causes of second cancers and the importance of long-term surveillance in survivors was the top story in hematology/oncology last week.
Another top story revealed GERD as a major factor in increased cancer risk. Studies have associated it with several cancer types, including esophageal adenocarcinoma, the most common type of esophageal cancer in the U.S.
Read these and more top stories in hematology/oncology below:
Second cancer in survivors a complex, multifaceted concern
Although many cancer survivors go on to live healthy, cancer-free lives, the prospect of facing cancer again is an ongoing concern. Read more.
GERD may increase risk for cancers of the larynx, esophagus
GERD appeared to increase the risk for esophageal adenocarcinoma, esophageal squamous cell carcinoma and laryngeal squamous cell carcinoma, according to results of a study published in Cancer. Read more.
Aspirin use may prolong survival for older patients with bladder, breast cancers
Any aspirin use and aspirin use at least three times per week appeared to be associated with improvements in survival outcomes among older adults with bladder and breast cancers, according to study results published in JAMA Network Open. Read more.
Current liver cancer screening protocols may miss at-risk Black individuals with HCV
Despite having better liver function at diagnosis, Black patients with hepatitis C virus tended to have more aggressive hepatocellular carcinoma tumors compared with other racial groups, according to a study published in Cancer. Read more.
Despite challenges, CAR-T may have ‘expanded role’ for children
Chimeric antigen receptor T-cell therapy has been heralded as a transformative addition to the cancer treatment armamentarium. Read more.